Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Neurochem Res
2009 Oct 01;3410:1738-47. doi: 10.1007/s11064-009-9983-y.
Show Gene links
Show Anatomy links
Modulation of glutamate and glycine transporters by niflumic, flufenamic and mefenamic acids.
Habjan S
,
Vandenberg RJ
.
???displayArticle.abstract???
Three fenamates--niflumic, flufenamic and mefenamic acids--were tested for effects on substrate-induced currents of glutamate and glycine transporters (EAAT1, EAAT2, GLYT1b and GLYT2a) expressed in Xenopus laevis oocytes. All fenamates inhibited EAAT1 currents; 100 microM flufenamic acid produced the most inhibition, decreasing the I (max) by 53 +/- 4% (P < 0.001). EAAT2 currents were less sensitive, but 100 microM flufenamic acid inhibited the I (max) by 34 +/- 5% (P = 0.006). All fenamates inhibited GLYT1b currents; 100 microM flufenamic acid produced the most inhibition, decreasing the I (max) by 61 +/- 1% (P < 0.001). At 100 microM, effects on the GLYT2a I (max) were mixed: 13 +/- 2% inhibition by flufenamic acid (P = 0.002), 30 +/- 6% enhancement by niflumic acid (P = 0.002), and no effect by mefenamic acid. Minor effects on substrate affinity suggested non-competitive mechanisms. These data could contribute to the development of selective transport modulators.
Aubrey,
Molecular basis for proton regulation of glycine transport by glycine transporter subtype 1b.
2000, Pubmed,
Xenbase
Aubrey,
Molecular basis for proton regulation of glycine transport by glycine transporter subtype 1b.
2000,
Pubmed
,
Xenbase
Bannwarth,
Clinical pharmacokinetics of nonsteroidal anti-inflammatory drugs in the cerebrospinal fluid.
1989,
Pubmed
Bhattacharyya,
Involvement of arginine 120, glutamate 524, and tyrosine 355 in the binding of arachidonate and 2-phenylpropionic acid inhibitors to the cyclooxygenase active site of ovine prostaglandin endoperoxide H synthase-1.
1996,
Pubmed
Chen,
Fenamates protect neurons against ischemic and excitotoxic injury in chick embryo retina.
1998,
Pubmed
Copeland,
Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase.
1994,
Pubmed
Cullen,
Pericapillary haem-rich deposits: evidence for microhaemorrhages in aging human cerebral cortex.
2005,
Pubmed
Dodd,
Excitotoxic mechanisms in the pathogenesis of dementia.
1994,
Pubmed
Drachman,
Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS.
2002,
Pubmed
Fairman,
Arachidonic acid elicits a substrate-gated proton current associated with the glutamate transporter EAAT4.
1998,
Pubmed
,
Xenbase
Gallagher,
Characterization of multiple forms of the human glycine transporter type-2.
1999,
Pubmed
Gasparini,
Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action.
2004,
Pubmed
Gögelein,
Flufenamic acid, mefenamic acid and niflumic acid inhibit single nonselective cation channels in the rat exocrine pancreas.
1990,
Pubmed
Greig,
The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs.
1997,
Pubmed
Halliwell,
Subunit-selective modulation of GABAA receptors by the non-steroidal anti-inflammatory agent, mefenamic acid.
1999,
Pubmed
,
Xenbase
Harks,
Fenamates: a novel class of reversible gap junction blockers.
2001,
Pubmed
Hogg,
Action of niflumic acid on evoked and spontaneous calcium-activated chloride and potassium currents in smooth muscle cells from rabbit portal vein.
1994,
Pubmed
Joo,
Mefenamic acid shows neuroprotective effects and improves cognitive impairment in in vitro and in vivo Alzheimer's disease models.
2006,
Pubmed
Ju,
Zn2+ inhibits glycine transport by glycine transporter subtype 1b.
2004,
Pubmed
,
Xenbase
Kalgutkar,
Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors.
2000,
Pubmed
Lee,
Inhibition of hKv2.1, a major human neuronal voltage-gated K+ channel, by meclofenamic acid.
1999,
Pubmed
Lerma,
Chloride transport blockers prevent N-methyl-D-aspartate receptor-channel complex activation.
1992,
Pubmed
Li,
Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression.
1997,
Pubmed
Liantonio,
Activation and inhibition of kidney CLC-K chloride channels by fenamates.
2006,
Pubmed
,
Xenbase
Malykhina,
Fenamate-induced enhancement of heterologously expressed HERG currents in Xenopus oocytes.
2002,
Pubmed
,
Xenbase
Mancini,
Arginine 120 of prostaglandin G/H synthase-1 is required for the inhibition by nonsteroidal anti-inflammatory drugs containing a carboxylic acid moiety.
1995,
Pubmed
McGeer,
Anti-inflammatory drugs in the fight against Alzheimer's disease.
1996,
Pubmed
Mitrovic,
Zn(2+) inhibits the anion conductance of the glutamate transporter EEAT4.
2001,
Pubmed
Mitrovic,
Identification of functional domains of the human glutamate transporters EAAT1 and EAAT2.
1998,
Pubmed
,
Xenbase
Pearlman,
Arachidonic acid and anandamide have opposite modulatory actions at the glycine transporter, GLYT1a.
2003,
Pubmed
,
Xenbase
Poulsen,
Niflumic acid modulates uncoupled substrate-gated conductances in the human glutamate transporter EAAT4.
2001,
Pubmed
,
Xenbase
Pouplana,
The structural and electronical factors that contribute affinity for the time-dependent inhibition of PGHS-1 by indomethacin, diclofenac and fenamates.
1999,
Pubmed
Rome,
Structural requirements for time-dependent inhibition of prostaglandin biosynthesis by anti-inflammatory drugs.
1975,
Pubmed
Scott,
Aberrant expression of the glutamate transporter excitatory amino acid transporter 1 (EAAT1) in Alzheimer's disease.
2002,
Pubmed
Seal,
Sulfhydryl modification of V449C in the glutamate transporter EAAT1 abolishes substrate transport but not the substrate-gated anion conductance.
2001,
Pubmed
Sinkkonen,
Receptor subtype-dependent positive and negative modulation of GABA(A) receptor function by niflumic acid, a nonsteroidal anti-inflammatory drug.
2003,
Pubmed
,
Xenbase
Smith,
Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs.
1995,
Pubmed
Smolinske,
Toxic effects of nonsteroidal anti-inflammatory drugs in overdose. An overview of recent evidence on clinical effects and dose-response relationships.
1990,
Pubmed
Szekely,
Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review.
2004,
Pubmed
Vandenberg,
Allosteric modulation of neurotransmitter transporters at excitatory synapses.
2004,
Pubmed
Vandenberg,
Molecular basis for differential inhibition of glutamate transporter subtypes by zinc ions.
1998,
Pubmed
,
Xenbase
Vandenberg,
Contrasting modes of action of methylglutamate derivatives on the excitatory amino acid transporters, EAAT1 and EAAT2.
1997,
Pubmed
,
Xenbase
White,
Niflumic and flufenamic acids are potent reversible blockers of Ca2(+)-activated Cl- channels in Xenopus oocytes.
1990,
Pubmed
,
Xenbase
Woodward,
Effects of fenamates and other nonsteroidal anti-inflammatory drugs on rat brain GABAA receptors expressed in Xenopus oocytes.
1994,
Pubmed
,
Xenbase
Zerangue,
Differential modulation of human glutamate transporter subtypes by arachidonic acid.
1995,
Pubmed
,
Xenbase
